Core Viewpoint - Vital Farms (VITL) has experienced a stock return of -15.1% over the past month, underperforming the Zacks S&P 500 composite's -7.5% and the Zacks Food - Miscellaneous industry's -0.9% [1] Earnings Estimate Revisions - The current quarter's earnings estimate for Vital Farms is projected at $0.28 per share, reflecting a decrease of -34.9% year-over-year, with a consensus estimate change of -27.7% over the last 30 days [4] - The consensus earnings estimate for the current fiscal year is $1.24, indicating a year-over-year increase of +5.1%, with a slight change of +0.3% in the last 30 days [4] - For the next fiscal year, the consensus earnings estimate is $1.52, representing a +22.3% change from the previous year, although it has decreased by -2.6% over the past month [5] Revenue Growth - The consensus sales estimate for the current quarter is $163.5 million, indicating a year-over-year increase of +10.5% [8] - For the current fiscal year, the sales estimate is $741.03 million, reflecting a +22.2% change, while the next fiscal year's estimate is $875.33 million, indicating an +18.1% change [8] Last Reported Results and Surprise History - In the last reported quarter, Vital Farms achieved revenues of $165.99 million, a year-over-year increase of +22.2%, with an EPS of $0.23 compared to $0.17 a year ago [9] - The reported revenues exceeded the Zacks Consensus Estimate of $160.23 million by +3.6%, and the EPS surprise was +53.33% [10] - The company has consistently beaten consensus EPS and revenue estimates in the trailing four quarters [10] Valuation - Vital Farms holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [6][15] - The Zacks Value Style Score grades Vital Farms as C, indicating it is trading at par with its peers [14]

Core Viewpoint - ASML has been trending in stock searches, prompting analysis of factors influencing its stock performance in the near future [1] Earnings Estimate Revisions - For the current quarter, ASML is expected to post earnings of $6.12 per share, reflecting an increase of +81.1% year-over-year, with a consensus estimate change of +1.6% over the last 30 days [5] - The consensus earnings estimate for the current fiscal year is $25.37, indicating a +21.9% change from the previous year, with a +0.8% change in the last 30 days [5] - For the next fiscal year, the consensus estimate is $29.55, showing a +16.5% change year-over-year, with a +1% change over the past month [6] Revenue Growth Projections - The consensus sales estimate for the current quarter is $8.08 billion, representing a +40.7% year-over-year change [9] - The sales estimates for the current and next fiscal years are $34.34 billion and $37.97 billion, indicating changes of +12.4% and +10.6%, respectively [9] Last Reported Results - ASML reported revenues of $9.88 billion in the last quarter, a +26.8% year-over-year increase, with an EPS of $7.30 compared to $5.60 a year ago [10] - The reported revenues exceeded the Zacks Consensus Estimate of $9.76 billion by +1.2%, and the EPS surprise was +1.67% [11] - ASML has consistently beaten consensus EPS and revenue estimates in the last four quarters [11] Valuation - ASML is graded D in the Zacks Value Style Score, indicating it is trading at a premium compared to its peers [15] - Valuation multiples such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF) are essential for assessing whether ASML's stock is overvalued, fairly valued, or undervalued [13][14] Overall Assessment - The Zacks Rank 3 suggests ASML may perform in line with the broader market in the near term, despite the market buzz [16]